PRODUCTION OF PROBIOTICS BY IN VITRO ENRICHMENT OF BENEFICIAL MICROORGANISMS FROM HUMAN OR ANIMAL MICROBIOTA
First Claim
Patent Images
1. A method for treatment of a dysbiotic condition in a subject comprising the steps of:
- a. obtaining a sample from said subject wherein said sample is obtained from the location of the dysbiotic condition and wherein said sample comprises micro-organisms;
b. in vitro culturing of said sample under conditions that favour beneficial micro-organisms;
c. re-introducing a sample of said cultured micro-organisms into said subject.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention is directed to a method of treating a dysbiosis in a mammal, preferably a human, by taking a sample of the micro-organisms that are causative of the dysbiosis, whereafter said sample is enriched in vitro for healthy bacteria, after which the sample is replaced.
-
Citations
20 Claims
-
1. A method for treatment of a dysbiotic condition in a subject comprising the steps of:
-
a. obtaining a sample from said subject wherein said sample is obtained from the location of the dysbiotic condition and wherein said sample comprises micro-organisms; b. in vitro culturing of said sample under conditions that favour beneficial micro-organisms; c. re-introducing a sample of said cultured micro-organisms into said subject. - View Dependent Claims (5, 6, 7, 8, 9, 10, 11, 12, 14, 15)
-
- 2. A probiotic composition comprising micro-organisms obtained by culturing a sample comprising micro-organisms obtained from a location of a dysbiotic condition in a subject, wherein the culturing is carried out under conditions that favour beneficial micro-organisms.
-
13. A method to prevent the occurrence of an auto-immune disease in children delivered through Caesarean section, comprising:
-
a. obtaining a vaginal microbiota sample from the mother at the time of delivery, or shortly before or after this time; b. optionally culturing said sample, during which culture said sample may optionally be enriched for beneficial micro-organisms; c. administration of at least a part of said sample obtained from step a or step b to the new-born child. - View Dependent Claims (16)
-
Specification